G. Campistron

731 total citations
32 papers, 632 citations indexed

About

G. Campistron is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Physiology. According to data from OpenAlex, G. Campistron has authored 32 papers receiving a total of 632 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 7 papers in Cellular and Molecular Neuroscience and 6 papers in Physiology. Recurrent topics in G. Campistron's work include Metabolism and Genetic Disorders (4 papers), Analytical Methods in Pharmaceuticals (4 papers) and Neuroscience and Neuropharmacology Research (4 papers). G. Campistron is often cited by papers focused on Metabolism and Genetic Disorders (4 papers), Analytical Methods in Pharmaceuticals (4 papers) and Neuroscience and Neuropharmacology Research (4 papers). G. Campistron collaborates with scholars based in France, Belgium and Canada. G. Campistron's co-authors include Georges Houin, M. Geffard, Rémy Burcelin, Cendrine Cabou, A. Calas, Daniel J. Drucker, J. Cros, J P Tillement, Laura Jung and Suzanne Trottier and has published in prestigious journals such as Journal of Neuroscience, Diabetes and The Journal of Comparative Neurology.

In The Last Decade

G. Campistron

32 papers receiving 606 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
G. Campistron France	14	202	176	133	124	116	32	632
Pieter Zandberg Netherlands	17	235 1.2×	226 1.3×	139 1.0×	115 0.9×	132 1.1×	29	851
Aya Fujinami Japan	18	191 0.9×	145 0.8×	181 1.4×	90 0.7×	145 1.3×	35	848
Belisario E. Fernández Argentina	18	154 0.8×	352 2.0×	154 1.2×	68 0.5×	259 2.2×	96	1.1k
Ana Belén Segarra Spain	16	187 0.9×	197 1.1×	215 1.6×	81 0.7×	180 1.6×	75	815
V. L. Raghavendra Rao Canada	20	310 1.5×	352 2.0×	196 1.5×	58 0.5×	59 0.5×	33	1.0k
M.K. Sim Singapore	20	291 1.4×	470 2.7×	191 1.4×	41 0.3×	156 1.3×	70	997
Yuichiro Kamikawa Japan	16	250 1.2×	237 1.3×	219 1.6×	45 0.4×	34 0.3×	55	707
I. Angel France	16	232 1.1×	267 1.5×	171 1.3×	119 1.0×	94 0.8×	35	670
Sören Siegmund Germany	19	271 1.3×	242 1.4×	148 1.1×	226 1.8×	189 1.6×	32	1.3k
L. B. Jellett Australia	10	230 1.1×	343 1.9×	183 1.4×	56 0.5×	46 0.4×	22	723

Countries citing papers authored by G. Campistron

Since Specialization

Citations

This map shows the geographic impact of G. Campistron's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Campistron with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Campistron more than expected).

Fields of papers citing papers by G. Campistron

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. Campistron. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Campistron. The network helps show where G. Campistron may publish in the future.

Co-authorship network of co-authors of G. Campistron

This figure shows the co-authorship network connecting the top 25 collaborators of G. Campistron. A scholar is included among the top collaborators of G. Campistron based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. Campistron. G. Campistron is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cabou, Cendrine, G. Campistron, Corinne Leloup, et al.. (2008). Brain Glucagon-Like Peptide-1 Regulates Arterial Blood Flow, Heart Rate, and Insulin Sensitivity. Diabetes. 57(10). 2577–2587. 98 indexed citations

Duvert, Michel, et al.. (1997). Distribution and role of aspartate in the nervous system of the chaetognathSagitta. The Journal of Comparative Neurology. 380(4). 485–494. 6 indexed citations

Salles, Jean‐Pierre, J Fauvel, A. Moisand, et al.. (1996). Increased content of annexin II (p36) and p11 in human placentabrush-border membrane vesicles during syncytiotrophoblast maturation and differentiation. Placenta. 17(8). 669–676. 28 indexed citations

Giroux, Michel, et al.. (1995). Effect of adrenaline on plasma concentrations of fentanyl during epidural anaesthesia for caesarean section. International Journal of Obstetric Anesthesia. 4(4). 225–229. 4 indexed citations

Giroux, Michel, et al.. (1991). Maternal and umbilical cord concentrations of fentanyl after epidural analgesia for cesarean section. European Journal of Obstetrics & Gynecology and Reproductive Biology. 42(2). 89–94. 28 indexed citations

Gilon, Patrick, Jérôme Mallefet, Stanislas Pauwels, et al.. (1990). Immunocytochemical and autoradiographic studies of the endocrine cells interacting with GABA in the rat stomach. Histochemistry and Cell Biology. 93(6). 645–654. 25 indexed citations

Giroux, Michel, G. Campistron, Fabrice Faure, et al.. (1990). Effects of pH on Antipyrine Transfer across the HumanPlacenta ex vivo. Developmental Pharmacology and Therapeutics. 14(3). 153–160. 16 indexed citations

Coulais, Yvon, et al.. (1989). Pharmacokinetics of Two Spiroarsoranes Administered Intravenously or Orally to Rabbits. Journal of Pharmaceutical Sciences. 78(3). 203–205. 2 indexed citations

Rovei, V., et al.. (1988). The pharmacokinetics of bendazac-lysine and 5-hydroxybendazac, its main metabolite, in patients with hepatic cirrhosis. European Journal of Clinical Pharmacology. 35(4). 391–396. 3 indexed citations

10.

Plusquellec, Y., G. Campistron, J. Barré, et al.. (1988). Pharmacokinetics of veralipride after chronic administration in humans. Journal of Pharmaceutical Sciences. 77(1). 64–67. 2 indexed citations

11.

Schiffmann, Serge N., G. Campistron, Jacques Brotchi, et al.. (1988). Immunocytochemical detection of GABAergic nerve cells in the human temporal cortex using a direct γ-aminobutyric acid antiserum. Brain Research. 442(2). 270–278. 33 indexed citations

12.

Rovei, V., et al.. (1987). Pharmacokinetics of bendazac-lysine and 5-hydroxybendazac in patients with renal insufficiency. European Journal of Clinical Pharmacology. 33(3). 303–310. 2 indexed citations

13.

Campistron, G., et al.. (1987). EFFECT OF SIZE AND DOSAGE STRENGTH ON THE BIOVAILABILITY OF TWO DILTIAZEM FORMULATIONS DURING REPEATED ADMINISTRATIONS IN HUMANS. Fundamental and Clinical Pharmacology. 1(1). 67–75. 3 indexed citations

14.

Geffard, M., et al.. (1987). An ultrastructural study of GABA-immunoreactive neurons and terminals in the septum of the rat. Journal of Neuroscience. 7(1). 48–54. 61 indexed citations

15.

Plusquellec, Y., G. Campistron, J. Barré, et al.. (1987). A double-peak phenomenon in the pharmacokinetics of veralipride after oral administration: A double-site model for drug absorption. Journal of Pharmacokinetics and Biopharmaceutics. 15(3). 225–239. 80 indexed citations

16.

Franchimont, P, et al.. (1984). Effects of arginine aspartate and its components on growth hormone, insulin and glucagon secretion in the rat.. PubMed. 267(1). 161–8. 5 indexed citations

17.

Campistron, G., et al.. (1983). Pharmacokinetics of arginine and aspartic acid administered simultaneously in the rat — III: Changes in the levels of amino acids in the plasma, liver and brain after simultaneous administration of arginine and aspartic acid. European Journal of Drug Metabolism and Pharmacokinetics. 8(3). 281–286. 1 indexed citations

18.

Campistron, G., et al.. (1982). Pharmacokinetics of arginine and aspartic acid administered simultaneously in the rat: I plasma kinetics. European Journal of Drug Metabolism and Pharmacokinetics. 7(4). 307–313. 7 indexed citations

19.

Campistron, G., et al.. (1982). Pharmacokinetics of arginine and aspartic acid administered simultaneously in the rat: II tisue distribution. European Journal of Drug Metabolism and Pharmacokinetics. 7(4). 315–322. 5 indexed citations

20.

Franchimont, P, A Luyckx, G. Campistron, & J. Cros. (1979). Effets de l'aspartate d'arginine sur la sécrétion de somatrotophine (STH), insuline et glucagon chez le rat.. Therapies. 34(5). 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact